Concepedia

Peter Ruf

PR

17

Publications

1.1K

Citations

15

H-Index

2001

Active since

Affiliations

Pharmalog (Germany)(Current)

Ludwig-Maximilians-Universität München

Helmholtz Zentrum München

Neovii Biotech (Germany)

LMU Klinikum

Peter Ruf is an author at Pharmalog (Germany) specializing in immunology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2001–2021

17

Publications

17

Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody

Peter Ruf, Horst Lindhofer · Blood · 2001 · 175 citations

Structural and functional characterization of the trifunctional antibody catumaxomab

Dirk Chelius, Peter Ruf, Patrick Gruber et al. · mAbs · 2010 · 141 citations · Full text

Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3)

Michael Jäger, A. Schoberth, Peter Ruf et al. · Cancer Research · 2011 · 116 citations · Full text

, , +21

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

Peter Ruf, Olivier Gires, Michael Jäger et al. · British Journal of Cancer · 2007 · 100 citations · Full text

The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2

Michael Jäger, A. Schoberth, Peter Ruf et al. · Cancer Research · 2009 · 93 citations · Full text

, , +15

Rows per page

1–5 of 17